64 / 164
194
9. Valderas JP, Irribarra V, Boza C, et al. Medical and surgical
treatments for obesity have opposite effects on peptide YY and
appetite: a prospective study controlled for weight loss. J Clin
Endocrinol Metab. 2010; 95: 1069-75.
10. Lahsen R, Berry M, Molina A. Cirugía Bariátrica en Pacientes
Diabéticos. En García de los Ríos M y Durruty P, ed.
Diabetes Mellitus, tercera edición. Santiago, 2014, Editorial
Mediterráneo, pp. 429-41.
11. Fried M, Ribaric G, Buchwald JN, Svacina S, Dolezanova K,
Scopinaro N. Metabolic surgery for the treatment of type
2 diabetes in patients with BMI
<
35 kg/m
2
: an integrative
review of early studies. Obes Surg. 2010; 20: 776-90.
12. Zhu L, Mo Z, Yang X, et al. Effect of laparoscopic Roux-en-Y
gastroenterostomy with BMI
<
35 kg/m
2
in type 2 diabetes
mellitus. Obes Surg. 2012; 22: 1562-7.
13. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg
BL, Cummings DE. Effects of gastric bypass surgery in patients
with type 2 diabetes and only mild obesity. Diabetes Care
2012; 35: 1420-8.
14. Lahsen R., Berry M., Lamoza P. Diabetes Improvement
Following Bariatric and Metabolic Surgery, Advanced
Bariatric and Metabolic Surgery, Dr. Chih-Kun Huang (Ed.),
ISBN: 978-953-307-926-4, InTech, DOI: 10.5772/33188.
Available
from:
http://www.intechopen.com/books/advanced-bariatric-and-metabolic-surgery/diabetes-
improvement-following-bariatric-and-metabolic-surgery
(2012).
15. Frühbeck G, Nogueiras R. GLP-1: the oracle for gastric bypass?
Diabetes 2014; 63: 399-401.
16. Jones AG, McDonald TJ, Shields BM, et al. Markers of
β
-cell
failure predict por glycemic response to GLP-1 receptor
agonist therapy in type 2 diabetes. Diabetes Care Publish
Ahead of Print, published online August 4, 2015.
17. Pinkney J. Bariatric Surgery for Diabetes: Gastric Banding is
Simple and Safe. Br J Diabetes Vasc Dis. 2010: 10: 139-42.
[REV. MED. CLIN. CONDES - 2016; 27(2) 188-194]